Massive Cervical Lymphadenopathy Post-COVID-19 Vaccination

Area of Science:

• Immunology
• Vaccinology
• Oncology

Background:

• The COVID-19 pandemic necessitated rapid development and deployment of mRNA vaccines.
• Mass vaccination programs increase the likelihood of observing treatment-related adverse events.
• Understanding vaccine side effects is crucial for public health and patient care.

Observation:

• A case study of a 58-year-old male presenting with massive cervical lymphadenopathy post-Moderna COVID-19 vaccination.
• Diagnostic investigations ruled out malignancy, attributing the condition to vaccine-related lymphadenopathy.
• The patient experienced rapid improvement with corticosteroid treatment.

Findings:

• Lymphadenopathy is identified as the second most frequent local reaction to the Moderna vaccine.
• This adverse event is characterized by significant swelling of lymph nodes, particularly in the cervical region.
• The condition is generally benign and responsive to treatment.

Implications:

• Increased awareness of vaccine-related lymphadenopathy is essential for healthcare providers.
• Prompt recognition can prevent misdiagnosis, especially in patients with a history of cancer.
• Effective management strategies, including corticosteroid use, can alleviate symptoms and improve patient outcomes.